An update on community-acquired pneumonia in adults.
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality, despite effective therapies. Guidelines for CAP management vary widely in their approach. Resistance of S pneumoniae to penicillins and other antibiotics has prompted evaluation of the new fluoroquinolones.
Gotfried
M
M
University of Arizona Medical College, USA.
Freeman
C
C
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D017714:Community-Acquired Infections; D024841:Fluoroquinolones; D006801:Humans; D007769:Lactams; D018942:Macrolides; D008875:Middle Aged; D011014:Pneumonia / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D013754:Tetracyclines; D014481:United States
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D007769:Lactams; D018942:Macrolides; D013754:Tetracyclines